Phibro Animal Health (PAHC) Income towards Parent Company (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly Income towards Parent Company of $24.0 million for Q1 2026, up 15.06% year-over-year from $20.9 million in Q1 2025, and down 12.51% quarter-over-quarter from $27.5 million in Q4 2025.
Phibro Animal Health (PAHC) Income towards Parent Company (2012 - 2026) Analysis & Trends
Phibro Animal Health's Income towards Parent Company history runs 15 years deep, the most recent figure standing at $24.0 million for Q1 2026.
- In Q1 2026, Income towards Parent Company rose 15.06% year-over-year to $24.0 million; the TTM figure through Mar 2026 stood at $95.2 million (up 783.22% YoY), while the FY2025 annual figure was $48.3 million, up 211.43% from the prior year.
- Income towards Parent Company for Q1 2026 stood at $24.0 million, down from $27.5 million in the prior quarter.
- The five-year high for Income towards Parent Company was $27.5 million in Q4 2025, with the low at -$45.0 million in Q2 2024.
- The 5-year median for Income towards Parent Company is $8.4 million (2024), against an average of $8.3 million.
- The sharpest annual moves came in 2024 and 2025: Income towards Parent Company slumped 491.19% in 2024, then surged 762.14% in 2025.
- Phibro Animal Health's Income towards Parent Company stood at $7.2 million in 2022, then slumped by 82.33% to $1.3 million in 2023, then soared by 150.0% to $3.2 million in 2024, then surged by 762.14% to $27.5 million in 2025, then declined by 12.51% to $24.0 million in 2026.
- Business Quant data shows PAHC's Income towards Parent Company at $24.0 million in Q1 2026, $27.5 million in Q4 2025, and $26.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Phibro Animal Health | 1.44 Bn | 1.36 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.02 Mn |
| Dec 31, 2025 | 27.46 Mn |
| Sep 30, 2025 | 26.53 Mn |
| Jun 30, 2025 | 17.22 Mn |
| Mar 31, 2025 | 20.88 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | -44.98 Mn |
| Mar 31, 2024 | 8.41 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | -8.02 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 10.04 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 7.49 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 17.47 Mn |
| Sep 30, 2021 | 6.53 Mn |
| Jun 30, 2021 | 14.94 Mn |